NEWRON PHARMACEUT. EO-20 (NP5) — Defensive Interval Ratio
NEWRON PHARMACEUT. EO-20 (NP5) has a Defensive Interval Ratio of 226 days as of June 2025. Defensive assets of €24.80 Million (cash €-, short-term investments €16.56 Million, receivables €8.24 Million) cover 226 days of daily cash needs of €109.81K/day. Check NP5 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
NEWRON PHARMACEUT. EO-20 Defensive Interval Ratio (2005–2024)
This chart shows how NEWRON PHARMACEUT. EO-20's Defensive Interval Ratio has evolved across 16 annual periods from 2005 to 2024. As of June 2025, the ratio stands at 226 days, meaning defensive assets of €24.80 Million can fund 226 days of operations without new revenue. Also explore net asset momentum of NEWRON PHARMACEUT. EO-20 to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for NEWRON PHARMACEUT. EO-20 (2005–2024)
The table below presents the year-by-year Defensive Interval Ratio for NEWRON PHARMACEUT. EO-20 from 2005 to 2024, covering 16 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see NEWRON PHARMACEUT. EO-20 stock valuation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 704 days | €45.32 Million | €64.40K/day | €- | €2.89 Million | ▲ +593 days |
| 2023 | 111 days | €8.79 Million | €79.25K/day | €- | €6.26 Million | ▼ -707 days |
| 2022 | 818 days | €11.29 Million | €13.81K/day | €- | €9.35 Million | ▼ -269 days |
| 2021 | 1087 days | €10.88 Million | €10.01K/day | €- | €9.57 Million | ▼ -219 days |
| 2020 | 1306 days | €24.66 Million | €18.88K/day | €- | €18.04 Million | ▲ +76 days |
| 2019 | 1230 days | €18.86 Million | €15.33K/day | €- | €17.11 Million | ▼ -209 days |
| 2018 | 1439 days | €17.47 Million | €12.14K/day | €- | €16.23 Million | ▼ -144 days |
| 2017 | 1583 days | €20.50 Million | €12.95K/day | €- | €19.44 Million | ▲ +1317 days |
| 2016 | 266 days | €4.85 Million | €18.21K/day | €- | €3.52 Million | ▼ -78 days |
| 2015 | 344 days | €6.14 Million | €17.84K/day | €- | €4.92 Million | ▼ -441 days |
| 2014 | 785 days | €9.66 Million | €12.30K/day | €- | €6.95 Million | ▲ +323 days |
| 2013 | 462 days | €7.68 Million | €16.63K/day | €- | €5.46 Million | ▲ +283 days |
| 2012 | 179 days | €5.68 Million | €31.74K/day | €- | €3.64 Million | ▼ -14 days |
| 2011 | 192 days | €1.49 Million | €7.75K/day | €- | €- | ▲ +125 days |
| 2009 | 68 days | €1.60 Million | €23.71K/day | €- | €1.60 Million | ▼ -97 days |
| 2005 | 164 days | €2.30 Million | €14.02K/day | €- | €- | — |